Tanarra Capital

Tanarra Capital is a private equity and venture capital firm based in Melbourne, Australia, with additional offices in Sydney, Perth, Auckland, and Hong Kong. Founded in 2005 by John Wylie, a well-regarded figure in the investment banking sector, the firm focuses on early-stage ventures and investments in both private and public companies. Tanarra Capital's investment strategy encompasses a diverse range of sectors, including financial services, healthcare, consumer markets, and education. The firm has made notable investments in various companies, such as Pexip, a leading video technology provider, and Genomics, which utilizes genetic analysis for enhancing pharmaceutical research and development. Tanarra Capital also has a history of investing in media, exemplified by its previous involvement with Business Spectator, a publication acquired by News Corporation.

David Birkbeck

Principal and CFO

Ravi Jeyaraj

Head of Private Equity

Andrew King

Principal

Neil Vinson

Investment Manager

David Wright

Investment Manager

John Wylie

CEO and Founder

9 past transactions

OXECO

Venture Round in 2022
OXECO is a chemistry technology firm specializing in the creation and manufacture of specialty chemicals for the clean technology and transportation industries. The company employs advanced carbene technology through its innovative ONTOTM platform, which allows for precise control over surface behavior. OXECO provides a range of surface treatment chemicals, including practical surface treatments, chemical insertions, and coatings that are both hydrophobic and hydrophilic. This enables clients to effectively modify and enhance the performance of surfaces in various applications.

Health Metrics

Acquisition in 2021
Health Metrics is a provider of software solutions.

August Robotics

Series A in 2020
August Robotics Pty. Ltd. is a robotics and artificial intelligence company based in Melbourne, Australia, with additional offices in Shenzhen, China, and Kowloon Tong, Hong Kong. Founded in 2016, the company focuses on designing and manufacturing application-specific robots that automate workflows primarily in the business-to-business sector. August Robotics specializes in creating robots that assist exhibition companies in optimizing the setup of trade shows, thereby streamlining processes and enhancing operational efficiency. The company distributes its products across Western Europe, North America, and the Asia Pacific, aiming to improve labor-intensive tasks through collaboration between robots and humans, ultimately benefiting both employees and businesses.

Inx Software

Acquisition in 2019
INX Software Pty Ltd, based in Perth, Australia, specializes in integrated workforce management software designed to enhance safety, logistics, compliance, and risk management. The company offers a comprehensive solution that encompasses training, competence tracking, stakeholder management, environmental considerations, and occupational health and hygiene, all centralized within a single database. With a user base exceeding 500,000 individuals across more than 23 countries, INX Software's platform facilitates cloud hosting, predictive analytics, and technical implementation services. By leveraging these capabilities, the software enables organizations to create safer, smarter, and more sustainable workplaces while efficiently managing compliance and reducing operational risks.

Genomics

Series B in 2018
Genomics PLC is focused on advancing the use of genomic data to transform healthcare. The company develops algorithms and software solutions that facilitate the analysis of large genomic and phenotypic datasets, aimed at understanding human biology and improving disease diagnosis and treatment. Its offerings serve a diverse range of clients, including governments, healthcare providers, pharmaceutical companies, and research laboratories. By providing tools that enhance the accuracy of genetic analysis, Genomics PLC helps de-risk the drug development process and enables clinicians to better identify individuals at risk for specific diseases. Founded in 2014 and based in Oxford, United Kingdom, the company aims to set standards in genomic data application, ultimately benefiting organizations and patients alike through innovative healthcare solutions.

Animal Dynamics

Series A in 2018
Animal Dynamics specializes in developing advanced robotics inspired by the efficiency and elegance found in nature. The company leverages recent advancements in analytical technologies to deeply analyze high-performance animals, aiming to understand the fundamental mechanisms that drive their capabilities. By merging fine engineering with insights from evolutionary biomechanics, Animal Dynamics creates innovative robotic vehicles designed for various applications, including crop spraying, surveying, fire suppression, humanitarian efforts, emergency aid, and military resupply. Their approach not only seeks to replicate natural designs but also aims to surpass existing engineering capabilities, contributing to both the advancement of technology and environmental protection.

Genomics

Series B in 2018
Genomics PLC is focused on advancing the use of genomic data to transform healthcare. The company develops algorithms and software solutions that facilitate the analysis of large genomic and phenotypic datasets, aimed at understanding human biology and improving disease diagnosis and treatment. Its offerings serve a diverse range of clients, including governments, healthcare providers, pharmaceutical companies, and research laboratories. By providing tools that enhance the accuracy of genetic analysis, Genomics PLC helps de-risk the drug development process and enables clinicians to better identify individuals at risk for specific diseases. Founded in 2014 and based in Oxford, United Kingdom, the company aims to set standards in genomic data application, ultimately benefiting organizations and patients alike through innovative healthcare solutions.

Arctoris

Pre Seed Round in 2018
Arctoris Limited, founded in 2016 and headquartered in Oxford, United Kingdom, operates the world’s first fully automated drug discovery platform. The company provides an online platform that facilitates data generation, secure storage, analysis, and visualization for researchers and biotech entrepreneurs engaged in cellular and molecular biology experiments. Utilizing advanced robotics and artificial intelligence, Arctoris enables rapid and cost-effective access to a variety of biochemical, cell-based, and molecular biology assays. This automation allows clients, including biotech and pharmaceutical companies as well as academic institutions, to make informed decisions based on high-quality, structured data. By streamlining the drug discovery process, Arctoris aims to accelerate the advancement of new drug programs towards clinical application.

Ultromics

Series A in 2018
Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. The company leverages artificial intelligence to create diagnostic tools that significantly improve the accuracy of echocardiography, with reported enhancements exceeding 90%. Ultromics' technology focuses on analyzing complex data from electrocardiograms, enabling healthcare providers to make informed decisions in diagnosing coronary artery disease. By providing innovative solutions for cardiologists, Ultromics aims to transform cardiovascular diagnostics and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.